Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118439) titled 'A clinical study on adebrelimab combined with chemotherapy for adjuvant treatment after surgical resection of locally advanced esophageal squamous cell carcinoma' on Feb. 5.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: The First Affiliated Hospital of Anhui Medical University
Condition:
Esophageal cancer
Intervention:
Group 1:Adbelimab combined with chemotherapy for adjuvant treatment after surgery
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-02-09
Target Sample Size: Group 1:60;Group 2:60;
Countries of Recruitment:
China
To k...